World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
28211
World Ranking
18289
National Ranking
9124

Gary D. Tollefson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gary D. Tollefson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 302 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gary D. Tollefson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gary D. Tollefson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 77 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Gary D. Tollefson is affiliated with Eli Lilly in the United States, contributing to research primarily within that geographic and institutional context.

Their recent scholarly output includes a paper titled Time-Lapse Mapping of Cortical Changes in Schizophrenia with Different Treatments, published in 2020 through UNC Libraries.

Frequent collaborators in their work include:

  • Paul M. Thompson
  • George Bartzokis
  • Kiralee M. Hayashi
  • Andrea D. Klunder
  • Po H. Lu

The main venue for Gary D. Tollefson's published research is UNC Libraries.

Best Publications

  • Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression

    Mauricio Tohen;Mauricio Tohen;Eduard Vieta;Joseph R Calabrese;Terence A. Ketter

  • Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.

    Gary D. Tollefson;Charles M. Beasley;Pierre V. Tran;Jamie S. Street

  • Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial

    Charles M Beasley;Gary Tollefson;Pierre Tran;Winston Satterlee

  • Antipsychotic drug effects on brain morphology in first-episode psychosis

    Jeffrey A. Lieberman;Jeffrey A. Lieberman;Gary D. Tollefson;Cecil Charles;Robert Zipursky

  • Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

    Pierre V. Tran;Susan H. Hamilton;Amy J. Kuntz;Janet H. Potvin

  • Olanzapine Versus Placebo in the Treatment of Acute Mania

    M. Tohen;T. M. Sanger;S. L. Mcelroy;G. D. Tollefson

  • Efficacy of olanzapine in acute bipolar mania: A double-blind, placebo-controlled study

    Mauricio Tohen;Thomas G. Jacobs;Starr L. Grundy;Susan L. McElroy

  • A novel augmentation strategy for treating resistant major depression.

    Richard C. Shelton;Gary D. Tollefson;Mauricio Tohen;Stephen Stahl

  • Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: A double-blind, randomized, placebo-controlled trial

    Jamie S. Street;W. Scott Clark;Kimberley S. Gannon;Jeffrey L. Cummings

  • Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease.

    Neil C. Bodick;Walter W. Offen;Allan I. Levey;Neal R. Cutler

  • Neuropsychological Change in Early Phase Schizophrenia During 12 Months of Treatment With Olanzapine, Risperidone, or Haloperidol

    Scot E. Purdon;Barry D. W. Jones;Barry D. W. Jones;Emanuel Stip;Alan Labelle

  • Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.

    Mauricio Tohen;Mauricio Tohen;K. N. Roy Chengappa;Trisha Suppes;Carlos A. Zarate

  • Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial.

    Beasley Cm;Sanger T;Satterlee W;Tollefson G

  • Comparative Efficacy and Safety of Atypical and Conventional Antipsychotic Drugs in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Haloperidol

    Jeffrey A. Lieberman;Gary Tollefson;Mauricio Tohen;Alan I. Green

  • Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.

    Bruce J. Kinon;Bruce R. Basson;Julie A. Gilmore;Gary D. Tollefson

  • Comparative Effect of Atypical and Conventional Antipsychotic Drugs on Neurocognition in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Low Doses of Haloperidol

    Richard S E Keefe;Larry J Seidman;Bruce K Christensen;Robert M Hamer

  • A Multicenter Investigation of Fixed-Dose Fluoxetine in the Treatment of Obsessive-compulsive Disorder

    Gary D. Tollefson;Alvin H. Rampey;Janet H. Potvin;Michael A. Jenike

  • Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial

    Charles M Beasley;Susan H Hamilton;Ann Marie Crawford;Mary Anne Dellva

  • Rational Design of a Combination Medication for the Treatment of Obesity

    Frank L. Greenway;M.J. Whitehouse;Maria Guttadauria;James W. Anderson

  • Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine.

    Tollefson Gd;Sanger Tm

Frequent Co-Authors

Mauricio Tohen
Mauricio Tohen University of New Mexico
Michael A. Cowley
Michael A. Cowley Monash University
Jeffrey A. Lieberman
Jeffrey A. Lieberman Columbia University
Tonmoy Sharma
Tonmoy Sharma King's College London
Diana O. Perkins
Diana O. Perkins University of North Carolina at Chapel Hill
Joseph P. McEvoy
Joseph P. McEvoy Augusta University
René S. Kahn
René S. Kahn Icahn School of Medicine at Mount Sinai
Alan Breier
Alan Breier Indiana University
Robert B. Zipursky
Robert B. Zipursky University of Toronto
Raquel E. Gur
Raquel E. Gur University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students exploring healthcare careers that complement a medical degree, a variety of online options are available. Many turn to online nursing courses for a flexible, affordable way to start or advance their nursing journey. These programs can be a stepping stone to broader opportunities in patient care and healthcare management.

For registered nurses seeking career progression, understanding the average cost of rn to bsn programs is crucial. RN to BSN programs, available online, offer a practical route for nurses to earn a bachelor’s degree with minimal disruption to their working life.

Aspiring nurse leaders and educators might consider the cheapest phd nursing programs, which prepare graduates for research and advanced teaching roles in the fast-growing healthcare sector.

For those without a nursing background, msn direct entry programs online offer a streamlined path to an advanced nursing degree, opening doors to specialized roles and higher salaries.

Best Scientists Citing Gary D. Tollefson

Trending Scientists

Recently Published Articles